[Diagnostic effectiveness and safety of currently available X-ray contrast media].
Sergeev
P V
PV
Russian State Medical University, Ministry of Public Health of Russian Federation.
Sviridov
N K
NK
Poliaev
Iu A
IuA
Shimanovskiĭ
N L
NL
D000293:Adolescent; D000328:Adult; D000367:Age Factors; D000792:Angiography; D000818:Animals; D002648:Child; D002675:Child, Preschool; D003287:Contrast Media / Q000009:adverse effects; D017023:Coronary Angiography; D003973:Diatrizoate / Q000009:adverse effects; D005069:Evaluation Studies as Topic; D005260:Female; D006321:Heart / Q000187:drug effects; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D007451:Iodamide / Q000009:adverse effects; D007472:Iohexol / Q000009:adverse effects / Q000031:analogs & derivatives; D007479:Iopamidol / Q000009:adverse effects; D007483:Iothalamic Acid / Q000009:adverse effects / Q000031:analogs & derivatives; D007485:Ioxaglic Acid / Q000009:adverse effects; D007668:Kidney / Q000187:drug effects; D008297:Male; D008875:Middle Aged; D012307:Risk Factors; D012449:Safety; D014283:Triiodobenzoic Acids / Q000009:adverse effects
D003287:Contrast Media; D014283:Triiodobenzoic Acids; D003973:Diatrizoate; D007483:Iothalamic Acid; C033300:iotrolan; D007472:Iohexol; D007451:Iodamide; C038192:iopromide; C053571:iopentol; C002587:ioxitalamic acid; C055357:ioxilan; C044834:iodixanol; D007479:Iopamidol; C054871:ioversol; D007485:Ioxaglic Acid